Literature DB >> 29313116

Importance of dynamic central venous pressure in Fontan circulation.

JeongHye Kim1, Seiko Kuwata1, Clara Kurishima1, Yoichi Iwamoto1, Hirotaka Ishido1, Satoshi Masutani1, Hideaki Senzaki2.   

Abstract

We tested our hypotheses that central venous pressure (CVP) shows an excessive increase in response to volume overload in Fontan circulation according to the extent of the reduction in venous capacitance (Cv), and that the maximum CVP after volume loading is associated with hepatic congestion. Changes in CVP after angiography (volume loading) were examined in 40 patients with Fontan circulation and 29 controls with biventricular circulation. CVP significantly increased with angiography in both groups, but the changes were much more evident in the Fontan group than in controls (3.3 ± 2.0 vs. 0.9 ± 1.4 mmHg, p = 0.0003). Multivariate analysis demonstrated that reduced Cv was the only significant determinant of CVP increase, independent of the amount of injected contrast medium, blood volume, pulmonary resistance, and ventricular diastolic stiffness (p < 0.05). Importantly, the use of a venodilator was associated with increased Cv and the resultant suppression of CVP elevation with volume load. In addition, CVP levels both at baseline (p = 0.02) and after volume loading (p = 0.01) were weakly but significantly correlated with the plasma levels of γ-glutamyl transpeptidase, a marker of hepatic congestion; however, multivariate analysis revealed that the CVP level after volume loading was a more important determinant of hepatic congestion. The results of this study highlight the importance of assessing dynamic in addition to static CVP for a better understanding of Fontan circulation. The potential importance of Cv as a therapeutic target for improving Fontan physiology needs further elucidation.

Entities:  

Keywords:  Dynamic CVP; Fontan circulation; Venous capacitance

Mesh:

Year:  2018        PMID: 29313116     DOI: 10.1007/s00380-017-1109-x

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  22 in total

1.  Changes in venous return parameters associated with univentricular Fontan circulations.

Authors:  L Macé; P Dervanian; A Bourriez; G M Mazmanian; V Lambert; J Losay; J Y Neveux
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-11       Impact factor: 4.733

2.  Impaired cerebral perfusion after bilateral pulmonary arterial banding in patients with hypoplastic left heart syndrome.

Authors:  Hirofumi Saiki; Clara Kurishima; Satoshi Masutani; Masanori Tamura; Hideaki Senzaki
Journal:  Ann Thorac Surg       Date:  2013-08-28       Impact factor: 4.330

3.  Assessment of central venous physiology of Fontan circulation using peripheral venous pressure.

Authors:  Satoshi Masutani; Clara Kurishima; Akiko Yana; Seiko Kuwata; Yoichi Iwamoto; Hirofumi Saiki; Hirotaka Ishido; Hideaki Senzaki
Journal:  J Thorac Cardiovasc Surg       Date:  2016-12-19       Impact factor: 5.209

4.  Influence of Left Ventricular Stiffness on Hemodynamics in Patients With Untreated Atrial Septal Defects.

Authors:  Clara Kurishima; Ryo Inuzuka; Seiko Kuwata; Yoichi Iwamoto; Masaya Sugimoto; Hirofumi Saiki; Hirotaka Ishido; Satoshi Masutani; Hideaki Senzaki
Journal:  Circ J       Date:  2015-05-20       Impact factor: 2.993

5.  Predictors of outcome after the Fontan operation: is hypoplastic left heart syndrome still a risk factor?

Authors:  J William Gaynor; Nancy D Bridges; Mitchell I Cohen; William T Mahle; William M Decampli; James M Steven; Susan C Nicolson; Thomas L Spray
Journal:  J Thorac Cardiovasc Surg       Date:  2002-02       Impact factor: 5.209

6.  Cardiac hepatopathy before and after heart transplantation.

Authors:  Wolfgang Dichtl; Wolfgang Vogel; Karin M Dunst; Wilhelm Grander; Hannes F Alber; Matthias Frick; Herwig Antretter; Günther Laufer; Otmar Pachinger; Gerhard Pölzl
Journal:  Transpl Int       Date:  2005-06       Impact factor: 3.782

7.  Improved early morbidity and mortality after Fontan operation: the Mayo Clinic experience, 1987 to 1992.

Authors:  F Cetta; R H Feldt; P W O'Leary; D D Mair; C A Warnes; D J Driscoll; D J Hagler; C J Porter; K P Offord; H V Schaff; F J Puga; G K Danielson
Journal:  J Am Coll Cardiol       Date:  1996-08       Impact factor: 24.094

8.  Portal and sinusoidal fibrosis are common on liver biopsy after Fontan surgery.

Authors:  Matthew C Schwartz; Lisa M Sullivan; Andrew C Glatz; Elizabeth Rand; Pierre Russo; David J Goldberg; Jonathan J Rome; Meryl S Cohen
Journal:  Pediatr Cardiol       Date:  2012-06-14       Impact factor: 1.655

9.  Bosentan induces clinical, exercise and hemodynamic improvement in a pre-transplant patient with plastic bronchitis after Fontan operation.

Authors:  Sotiria C Apostolopoulou; John Papagiannis; Spyridon Rammos
Journal:  J Heart Lung Transplant       Date:  2005-08       Impact factor: 10.247

10.  Clinical outcome of patients 20 years after Fontan operation--effect of fenestration on late morbidity.

Authors:  Masamichi Ono; Dietmar Boethig; Heidi Goerler; Melanie Lange; Mechthild Westhoff-Bleck; Thomas Breymann
Journal:  Eur J Cardiothorac Surg       Date:  2006-10-30       Impact factor: 4.191

View more
  4 in total

1.  ISL1 loss-of-function mutation contributes to congenital heart defects.

Authors:  Lan Ma; Juan Wang; Li Li; Qi Qiao; Ruo-Min Di; Xiu-Mei Li; Ying-Jia Xu; Min Zhang; Ruo-Gu Li; Xing-Biao Qiu; Xun Li; Yi-Qing Yang
Journal:  Heart Vessels       Date:  2018-11-02       Impact factor: 2.037

2.  Forns Index is a predictor of cardiopulmonary bypass time and outcomes in Fontan conversion.

Authors:  Gaku Izumi; Atsuhito Takeda; Hirokuni Yamazawa; Osamu Sasaki; Nobuyasu Kato; Hidetsugu Asai; Tsuyoshi Tachibana; Yoshiro Matsui
Journal:  Heart Vessels       Date:  2019-09-27       Impact factor: 2.037

3.  Clinical Significance of Central Venous Pressure During Exercise After Fontan Procedure.

Authors:  Seiji Asagai; Kei Inai; Eriko Shimada; Gen Harada; Hisashi Sugiyama
Journal:  Pediatr Cardiol       Date:  2019-11-11       Impact factor: 1.655

4.  Induction of aggressive arterial and venous dilation therapy in addition to pulmonary dilation therapy (super-Fontan strategy) improves Fontan circulation both at rest and during treadmill exercise.

Authors:  Shoichi Ishikawa; Shun Matsumura; Akiko Yana; Clara Kurishima; Yoichi Iwamoto; Hirotaka Ishido; Satoshi Masutani; Ryo Nakagawa; Hideaki Senzaki
Journal:  JTCVS Open       Date:  2022-07-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.